SCHEMBL11144882

SCHEMBL11144882

COc1cccc(C)c1NC(=O)N=C1SCC(=O)N1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ MAPT P10636 3/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ DRD4 P21917 2/20 0.40
▸ CLK1 P49759 1/20 0.40
▸ ATM Q13315 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11150736 0.93 ALDH1A1 (0.48) ALDH1A1TDP1MAPTMAPK1KDM4E
SCHEMBL11150743 0.93 ALDH1A1 (0.48) ALDH1A1TDP1MAPTMAPK1KDM4E
SCHEMBL11147165 0.90 KMT2A (0.46) ALDH1A1TDP1MAPTMAPK1KDM4E
SCHEMBL11147166 0.90 KMT2A (0.46) ALDH1A1TDP1MAPTMAPK1KDM4E
SCHEMBL11144761 0.88 ALDH1A1 (0.44) ALDH1A1TDP1MAPTMAPK1KDM4E
SCHEMBL11151136 0.86 L3MBTL1 (0.42) ALDH1A1MEN1KMT2ADRD4ATM
SCHEMBL11141779 0.84 GRM5 (0.42) ALDH1A1MEN1KMT2ASMN1; SMN2PSMD14
SCHEMBL11144521 0.84 GRM5 (0.42) ALDH1A1MEN1KMT2ASMN1; SMN2PSMD14
SCHEMBL11146126 0.81 RIPK1 (0.40) ALDH1A1MAPTMAPK1MEN1KMT2A
SCHEMBL10991240 0.81 GRM5 (0.55) ALDH1A1MEN1KMT2ADRD4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4402964-A N-Aryl-N'-(3-methyl or ethyl-4-oxothiazolidinylidene)ureas useful for the treatment of epilepsy MCNEILAB, INC. (US) 1983-09-06 — — US disclosed
Send feedback